Addition of methadone to another opioid in the management of moderate to severe cancer pain: A case series

Journal of Palliative Medicine

Volumn 16, Issue 3, 2013, Pages 305-309

  Wallace, Elaine ^a   Ridley, Julia ^a,b   Bryson, John ^a,b   Mak, Ernie ^a,b   Zimmermann, Camilla ^a,b  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FENTANYL; GABAPENTIN; HYDROMORPHONE; METHADONE; MORPHINE SULFATE; OPIATE; OXYCODONE; PREGABALIN; SUFENTANIL;

ADD ON THERAPY; ADULT; AGED; ANALGESIA; ARTICLE; CANCER PAIN; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CLINICAL ARTICLE; CONSTIPATION; DISEASE SEVERITY; DROWSINESS; DRUG EFFICACY; DRUG RESPONSE; DRUG TOLERABILITY; FEMALE; FOLLOW UP; HUMAN; MALE; NAUSEA; NEUROPATHIC PAIN; OUTCOME ASSESSMENT; OUTPATIENT; PAIN ASSESSMENT; QT PROLONGATION; QUANTITATIVE ANALYSIS; SCORING SYSTEM; SYMPTOM ASSESSMENT;

AGED; AGED, 80 AND OVER; ANALGESICS, OPIOID; FEMALE; HUMANS; MALE; METHADONE; MIDDLE AGED; NEOPLASMS; PAIN; PAIN MEASUREMENT; PALLIATIVE CARE; RETROSPECTIVE STUDIES;

EID: 84874491260     PISSN: 10966218     EISSN: 15577740     Source Type: Journal    
DOI: 10.1089/jpm.2012.0335     Document Type: Article

References (21)

1. Fallon MT, Laird BJ: A systematic review of combination step III opioid therapy in cancer pain: An EPCRC opioid guideline project. Palliat Med 2011;25(5):597-603.
2. Ross FB, Smith MT: The intrinsic antinociceptive effects of oxycodone appear to be kappa-opioid receptor mediated. Pain 1997;73(2):151-157.
3. Pasternak GW: Incomplete cross tolerance and multiple mu opioid peptide receptors. Trends Pharmacol Sci 2001;22(2): 67-70.
4. Snyder SH: Opiate receptors and beyond: 30 years of neural signaling research. Neuropharmacology 2004;47 Suppl 1: 274-285.
5. Ross FB, Wallis SC, Smith MT: Co-administration of subantinociceptive doses of oxycodone and morphine produces marked antinociceptive synergy with reduced CNS sideeffects in rats. Pain 2000;84(2-3):421-428.
6. Vorobeychik Y, Chen L, Bush MC, Mao J: Improved opioid analgesic effect following opioid dose reduction. Pain Med 2008;9(6):724-727.
7. McKenna M, Nicholson AB: Use of methadone as a coanalgesic. J Pain Symptom Manage 2011;42(6):e4-6.
8. Haughey C, Watson M, White C: Use of methadone as a coanalgesic: Response to McKenna and Nicholson. J Pain Symptom Manage 2012;43(4):e5-6.
9. Dudgeon DJ, Harlos M, Clinch JJ: The Edmonton Symptom Assessment Scale (ESAS) as an audit tool. J Palliat Care 1999;15(3):14-19.
10. Moro C, Brunelli C, Miccinesi G, Fallai M, Morino P, Piazza M, et al.: Edmonton symptom assessment scale: Italian validation in two palliative care settings. Support Care Cancer 2006;14(1):30-37.
11. Chang VT, Hwang SS, Feuerman M: Validation of the Edmonton Symptom Assessment Scale. Cancer 2000;88(9): 2164-2171.
12. Osoba D, Slamon DJ, Burchmore M, Murphy M: Effects on quality of life of combined trastuzumab and chemotherapy in women with metastatic breast cancer. J Clin Oncol 2002; 20(14):3106-3113.
13. Joly F, Vardy J, Pintilie M, Tannock IF: Quality of life and/or symptom control in randomized clinical trials for patients with advanced cancer. Ann Oncol 2007;18(12):1935-1942.
14. Guyatt GH, Osoba D, Wu AW, Wyrwich KW, Norman GR: Methods to explain the clinical significance of health status measures. Mayo Clin Proc 2002;77(4):371-383.
15. Breitbart W, Chandler S, Eagel B, Ellison N, Enck RE, Lefkowitz M, et al.: An alternative algorithm for dosing transdermal fentanyl for cancer-related pain. Oncology (Williston Park) 2000;14(5):695-705 and 9-17.
16. Mercadante S, Caraceni A: Conversion ratios for opioid switching in the treatment of cancer pain: A systematic review. Palliat Med 2011;25(5):504-515.
17. Benitez-Rosario MA, Feria M, Salinas-Martin A, Martinez-Castillo LP, Martin-Ortega JJ: Opioid switching from transdermal fentanyl to oral methadone in patients with cancer pain. Cancer 2004;101(12):2866-2873.
18. Janssen-Cilag LTD: Summary of Product Characteristics, Durogesic DTrans. 2012. www.medicines.org.uk/emc/medicine/17086/spc (Last accessed February 12, 2012.)
19. Twycross R, Wilcock A (eds): Palliative Care Formulary, 4E. 2012. Pharmaceutical Press, London.
20. Bruera E, Sweeney C: Methadone use in cancer patients with pain: A review. J Palliat Med 2002;5(1):127-138.
21. Bryson J, Tamber A, Seccareccia D, Zimmermann C: Methadone for treatment of cancer pain. Curr Oncol Rep 2006; 8(4):282-288.